Analysts Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Target Price at $410.32

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned a consensus rating of “Moderate Buy” from the nineteen analysts that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $410.32.

Several equities analysts have recently weighed in on ISRG shares. Evercore ISI increased their price objective on shares of Intuitive Surgical from $385.00 to $425.00 and gave the company an “in-line” rating in a research report on Tuesday, July 2nd. Piper Sandler increased their price objective on shares of Intuitive Surgical from $435.00 to $490.00 and gave the company an “overweight” rating in a research report on Tuesday, July 9th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Citigroup upped their price target on shares of Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, BTIG Research upped their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 175 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the transaction, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Mark Brosius sold 175 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the transaction, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock worth $6,927,011 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after purchasing an additional 272,741 shares during the last quarter. Capital World Investors raised its holdings in Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after purchasing an additional 73,634 shares during the last quarter. Edgewood Management LLC raised its holdings in Intuitive Surgical by 7.9% during the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after purchasing an additional 374,667 shares during the last quarter. Finally, Fisher Asset Management LLC raised its holdings in Intuitive Surgical by 2.0% during the 4th quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock worth $1,516,222,000 after purchasing an additional 88,977 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.1 %

NASDAQ ISRG opened at $444.16 on Thursday. The firm’s fifty day moving average price is $417.08 and its two-hundred day moving average price is $390.78. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $449.00. The firm has a market capitalization of $157.54 billion, a P/E ratio of 80.17, a price-to-earnings-growth ratio of 5.73 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the prior year, the firm posted $1.00 earnings per share. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.